TE_83
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | MER4B |
|---|---|
| TE superfamily | ERV1 |
| TE class | LTR |
| Gene | SLC2A5 |
| Class | Chimeric |
| Coding | Non-coding |
| Tumor-specific score | 0.80 |
| Counts of samples | TCGA_tumor:228; TCGA_normal:22; GTEx:299 |
| TSS | chr1(-):9085638 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_83.1 | SLC2A5 | Chimeric | Non-coding | Non-coding | chr1(-):9041917,9041937,9047610,9047734,9057448,9057608,9058152,9058250,9069504,9069594,9085014,9085166,9085500,9085639 |
| teRNA_83.2 | SLC2A5 | Chimeric | Non-coding | Non-coding | chr1(-):9047714,9047734,9057448,9057608,9058152,9058250,9069504,9069594,9085014,9085142,9085500,9085639 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
